Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Rissmann

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Experimental Dermatology|August 8, 2008
Development of a murine model to evaluate the effect of vernix caseosa on skin barrier recoveryMarion H M Oudshoorn, Robert Rissmann, Dennis van der Coelen, et al.
Frontiers in Immunology|May 2, 2018
Complement Activation in Inflammatory Skin DiseasesJenny Giang, Marc A J Seelen, Martijn B A van Doorn, et al.
Frontiers in Oncology|September 15, 2022
Integration of healthy volunteers in early phase clinical trials with immuno-oncological compoundsIgor Radanovic, Naomi Klarenbeek, Robert Rissmann, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 6, 2023
The development of in vitro organotypic 3D vulvar models to study tumor-stroma interaction and drug efficacyShidi Wu, Bertine W Huisman, Marion H Rietveld, et al.
The Journal of Investigative Dermatology|August 3, 2007
Temperature-induced changes in structural and physicochemical properties of vernix caseosaRobert Rissmann, Hendrik W W Groenink, Gert S Gooris, et al.
Clinical and Translational Science|April 22, 2020
Antimicrobial Peptide Omiganan Enhances Interferon Responses to Endosomal Toll-Like Receptor Ligands in Human Peripheral Blood Mononuclear CellsHendrika W Grievink, Silvana M G Jirka, Tess D Woutman, et al.
Lasers in Surgery and Medicine|November 7, 2023
Needle-free electronically-controlled jet injector treatment with bleomycin and lidocaine is effective and well-tolerated in patients with recalcitrant keloidsVazula Zulfra Bekkers, Fatima Khan, Pim Aarts, et al.
Clinical and Translational Science|June 13, 2026
Interpretation of Chemistry, Hematology and Coagulation Laboratory Results in Early-Phase Clinical Pharmacology Trials; a Retrospective Analysis Based on the Placebo Arm of Randomized-Controlled TrialsJannik Rousel, Tessa Niemeyer-van der Kolk, Matthijs Moerland, et al.
British Journal of Clinical Pharmacology|April 11, 2016
Injection site reactions after subcutaneous oligonucleotide therapyLeonie van Meer, Matthijs Moerland, Jolie Gallagher, et al.
British Journal of Clinical Pharmacology|October 7, 2020
A randomized controlled trial with a delayed-type hypersensitivity model using keyhole limpet haemocyanin to evaluate adaptive immune responses in manMahdi Saghari, Pim Gal, Dimitrios Ziagkos, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Experimental Dermatology|August 8, 2008
Development of a murine model to evaluate the effect of vernix caseosa on skin barrier recoveryMarion H M Oudshoorn, Robert Rissmann, Dennis van der Coelen, et al.
Frontiers in Immunology|May 2, 2018
Complement Activation in Inflammatory Skin DiseasesJenny Giang, Marc A J Seelen, Martijn B A van Doorn, et al.
Frontiers in Oncology|September 15, 2022
Integration of healthy volunteers in early phase clinical trials with immuno-oncological compoundsIgor Radanovic, Naomi Klarenbeek, Robert Rissmann, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 6, 2023
The development of in vitro organotypic 3D vulvar models to study tumor-stroma interaction and drug efficacyShidi Wu, Bertine W Huisman, Marion H Rietveld, et al.
The Journal of Investigative Dermatology|August 3, 2007
Temperature-induced changes in structural and physicochemical properties of vernix caseosaRobert Rissmann, Hendrik W W Groenink, Gert S Gooris, et al.
Clinical and Translational Science|April 22, 2020
Antimicrobial Peptide Omiganan Enhances Interferon Responses to Endosomal Toll-Like Receptor Ligands in Human Peripheral Blood Mononuclear CellsHendrika W Grievink, Silvana M G Jirka, Tess D Woutman, et al.
Lasers in Surgery and Medicine|November 7, 2023
Needle-free electronically-controlled jet injector treatment with bleomycin and lidocaine is effective and well-tolerated in patients with recalcitrant keloidsVazula Zulfra Bekkers, Fatima Khan, Pim Aarts, et al.
Clinical and Translational Science|June 13, 2026
Interpretation of Chemistry, Hematology and Coagulation Laboratory Results in Early-Phase Clinical Pharmacology Trials; a Retrospective Analysis Based on the Placebo Arm of Randomized-Controlled TrialsJannik Rousel, Tessa Niemeyer-van der Kolk, Matthijs Moerland, et al.
British Journal of Clinical Pharmacology|April 11, 2016
Injection site reactions after subcutaneous oligonucleotide therapyLeonie van Meer, Matthijs Moerland, Jolie Gallagher, et al.
British Journal of Clinical Pharmacology|October 7, 2020
A randomized controlled trial with a delayed-type hypersensitivity model using keyhole limpet haemocyanin to evaluate adaptive immune responses in manMahdi Saghari, Pim Gal, Dimitrios Ziagkos, et al.
Pageof 10